You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Proteomics may be complicated, but that didn't stop these scientists from adding quantum physics to the mix.
The Wall Street Journal reports on Pfizer's anticipated new strategy.
Genome Technology hosts its first seminar today. There's still time to submit your career-related questions for the experts.
Mass spec, meet the cosmos.
The science crew at the New York Times launches a blog of their own.
Proving that good buzzwords never die, BioMed Central launches BMC Systems Biology, an open-access journal covering research in this community.
Nobel laureate Paul Nurse writes an opinion piece in the UK's Times to encourage people to let scientists explain a particular kind of stem cell research before banning it.
Berkeley, Calif., becomes the first city to regulate nanotechnology.
Can't get enough: Harvard announces a 50-year expansion plan, including a 500,000-square-foot science complex.
In this column from the RFID Journal, MIT engineer Stephen Miles updates readers on recent progress with the technology.
This week's issue of Science, boiled down for those who only have time to read during their coffee break.
The Omics! Omics! blog weighs in on a grand-scale effort to generate affinity reagents for the human proteome.
A PLoS Biology paper looks at mapping and validating transcriptional regulation in E. coli.
This week in Nature, plenty of good reads.
Check out the early edition of PNAS for reports on Parkinson's biomarkers and DNA folding.
In memoriam: Harvard biochemist Elkan Blout.
Still celebrating RNA: the 50th anniversary of Alexander Rich's double-stranded discovery.
In this PNAS paper, scientists pop on their sunglasses and check out DNA in all its ultraviolet-illuminated glory.
A bill to increase federal funding for embryonic stem cell research could reappear tomorrow in the US House of Representatives. Assuming it passes, Hill watchers say there may be enough votes to override a veto from President Bush.
A roundup of three papers in the current Nature Biotechnology.
Nature Genetics sees its chance to hop on the $1,000 genome bandwagon as experts weigh in on pie-in-the-sky sequencing plans.
Today's Science Times reports on a conservation genetics push to keep bison home on the range.
A profile of Craig Venter and his synthetic biology aspirations in The Atlantic Monthly may not do much for one scientist's modesty.
In this video, Sanger's Tim Hubbard presents the challenges of working with and keeping up with genomic data to the folks at Google.
Wired magazine ranks the top 10 cities where tech geeks rule the roost.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.